Search - tctmd.com

Displaying 601 - 620 of 630

Sort: Relevancy | Date

News Features

CMS Penalties Spur Efforts to Reduce 30-Day Hospital Readmissions

July 21, 2015

News Industry News

HeartWare launches European trial for next-gen MVAD heart pump

July 20, 2015

News Daily News

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Todd Neale

July 16, 2015

News Daily News

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Todd Neale

July 13, 2015

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

News Industry News

World's Smallest Pacemaker, Medtronic Micra TPS, Wins Top European Innovation Award for 2015

June 24, 2015

News Industry News

World's Smallest Pacemaker, Medtronic Micra TPS, Featured in Late-Breaking Trial Session at EUROPACE 2015

June 22, 2015

News Industry News

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

June 05, 2015

News Industry News

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

May 26, 2015

News Industry News

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

May 26, 2015

News Daily News

Long-term Ticagrelor Therapy Cost-Effective in US Patients

L.A. McKeown

February 02, 2015

News Daily News

‘Value’ of PCI Varies Widely Across VA Hospitals

Yael L. Maxwell

January 28, 2015

News Daily News

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

L.A. McKeown

January 12, 2015

News Daily News

Link Between PCI Volume and Outcomes Remains Intact

Todd Neale

September 13, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

News Daily News

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

Caitlin E. Cox

August 30, 2013

News Daily News

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

July 25, 2013

News Daily News

Most Hospital Readmissions Within 30 Days of PCI Unrelated to Index Procedure

March 28, 2013

News Daily News

Same-Day Discharge After Elective PCI Safe, Preferred by Most Patients

March 20, 2013

News Daily News

Meta-Analysis Finds No Clear Answer for Same-Day Discharge After PCI

Caitlin E. Cox

January 24, 2013

Advertisement

CMS Penalties Spur Efforts to Reduce 30-Day Hospital Readmissions

HeartWare launches European trial for next-gen MVAD heart pump

MVARC Document Offers Template for Mitral Valve Therapeutics Research

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

World's Smallest Pacemaker, Medtronic Micra TPS, Wins Top European Innovation Award for 2015

World's Smallest Pacemaker, Medtronic Micra TPS, Featured in Late-Breaking Trial Session at EUROPACE 2015

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

Long-term Ticagrelor Therapy Cost-Effective in US Patients

‘Value’ of PCI Varies Widely Across VA Hospitals

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

Link Between PCI Volume and Outcomes Remains Intact

Apixaban Cost-Effective Compared with Warfarin or Aspirin

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

Most Hospital Readmissions Within 30 Days of PCI Unrelated to Index Procedure

Same-Day Discharge After Elective PCI Safe, Preferred by Most Patients

Meta-Analysis Finds No Clear Answer for Same-Day Discharge After PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content